Envoy Medical to Showcase 24-Hour Hearing Implant on Bloomberg Television

Envoy Medical to Showcase 24-Hour Hearing Implant on Bloomberg Television

2026-06-13 companies

New York, Friday, 12 June 2026.
Tomorrow, Envoy Medical’s CEO takes to Bloomberg TV to discuss a fully implanted, 24-hour hearing device, a breakthrough poised to disrupt the growing $2 billion audiology market.

A Global Platform for Medical Innovation

On Saturday, June 13, 2026, Envoy Medical (NASDAQ:COCH) Chief Executive Officer Brent Lucas will take center stage on the “New to The Street” business broadcast [1][3]. The segment will shine a spotlight on the company’s pioneering medical technology: a fully implanted hearing device engineered to provide continuous, 24-hour auditory support [1][3]. This broadcast is strategically positioned for maximum visibility, airing across Bloomberg Television networks in the United States, Latin America, and the Middle East and North Africa (MENA) regions [1][3]. Furthermore, the media platform amplifies its reach through a dedicated YouTube channel that boasts a subscriber base exceeding 4.77 million users as of June 11, 2026 [1][3].

Despite the highly anticipated weekend broadcast, Envoy Medical faces near-term headwinds in the equity markets [GPT]. On Thursday, June 11, 2026, shares of Envoy Medical Inc. (COCH) experienced a decline, dropping by 3.48%—a decrease of $0.02—to settle at a fair market value of $0.64 as of 3:42 PM Eastern Time [2]. This recent downward price action reflects a broader trend of muted investor enthusiasm surrounding the stock in the days leading up to the television appearance [2].

A Multi-Billion Dollar Market Opportunity

The audiology sector presents a lucrative macroeconomic backdrop for Envoy Medical’s technological advancements [GPT]. According to a June 2026 industry report, the broader cochlear implants market was valued at a substantial $2 billion in the base year of 2025 [4]. Driven by increasing awareness and the implementation of early diagnosis protocols, this market is projected to expand at a compound annual growth rate (CAGR) of 7.6% between 2026 and 2035 [4]. By capitalizing on this compounding growth over a 10-year period, the global market valuation could reach approximately 4.161 billion dollars by 2035 [4].

Sources


Medical technology Envoy Medical